Pharmacists in Bremen, IN Accepting Medicare
5 Pharmacists found. Showing 1 - 5
 Diana Renee Mechelay, PHARMD Pharmacist - Ambulatory Care Medicare: Not Enrolled in Medicare Practice Location: 1120 W South St, Bremen, IN 46506 Phone: 574-335-7800 |
Jennifer Lynn Schnaible, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1150 W Plymouth St, Bremen, IN 46506 Phone: 574-546-3797 |
 Trevor Phenis, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1150 W Plymouth St, Bremen, IN 46506 Phone: 547-546-3797 |
Joseph Wayne Miller Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1150 W Plymouth St, Bremen, IN 46506 Phone: 574-546-3797 Fax: 574-546-3431 |
Ryan Libey Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3293 Elm Rd, Bremen, IN 46506 Phone: 574-936-9388 |
News Archive
Understanding the effects of psychotherapy in patients with borderline personality disorder
According to newly published research, a specialized psychotherapy has been linked to changes in activation patterns in certain areas of the brain in patients with borderline personality disorder (BPD), suggesting its impact may go deeper than symptom change.
Serum neurofilament levels can be used to differentiate between frontotemporal dementia and psychiatric disorders
Early symptoms of frontotemporal dementia are often confused with symptoms occurring in psychiatric disorders.
From Uber vouchers to patient advocates: What it takes to increase ER addiction treatment
For years, Kayla West watched the opioid epidemic tear through her eastern Tennessee community. As a psychiatric nurse practitioner, she treated people with mental illness but felt she needed to do more to address addiction.
Awake mental replay essential for making informed choices
Awake mental replay of past experiences is essential for making informed choices, suggests a study in rats. Without it, the animals- memory-based decision-making faltered, say scientists funded by the National Institutes of Health. The researchers blocked learning from, and acting on, past experience by selectively suppressing replay - encoded as split-second bursts of neuronal activity in the memory hubs of rats performing a maze task.
Pharming, Santarus begin RHUCIN Phase IIIb study in patients with Hereditary Angioedema
Specialty biopharmaceutical company Santarus, Inc. and biotech company Pharming Group NV (NYSE Euronext: PHARM) today announced that Pharming has begun an international, multicenter, randomized, placebo-controlled Phase IIIb clinical study evaluating the investigational drug RHUCIN for the treatment of acute attacks of angioedema in patients with Hereditary Angioedema.
› Verified 6 days ago